ANSEA - ADVISORY BOARD
Helping us stay ahead of industry trends and navigate complex healthcare issues

Our advisory board is composed of individuals with diverse backgrounds and expertise, which allows us to gain a holistic perspective on the strategic issues we face. Our advisory board members come from a variety of industries, including healthcare, pharmaceuticals, finance, and academia, and bring with them a wealth of knowledge and experience.

They work closely with our leadership team and are actively involved in providing strategic guidance and directions. Thanks to their guidance, we are able to deliver high-quality services that help our clients achieve their business goals.

The Brain Trust
Our Trailblazing Advisors

Bruno Occhipinti

Bruno is a highly experienced business leader and strategist with expertise in healthcare, medtech, and technology. He has worked for major companies such as Philips, Samsung, and Hyperion (Oracle), leading various projects and developing new business in the APAC region. Bruno holds an MBA from the Wharton School and a Master’s degree in International Finance and Entrepreneurship.

Dr. P.V. Venugopal​

Dr. Venugopal is a seasoned professional with extensive experience in public-private partnerships and neglected diseases. He served the Government of India for 20 years and spent a decade as Executive Director at Dr. Reddy’s Laboratories. He was a pharmaceutical consultant for the World Bank and served on various scientific committees. He holds a BSc in Physics, a BE, and a PhD.

Mohamad Rammal

Mohamad Rammal is an experienced pharma leader with over 23 years of experience working for top MNCs in Switzerland, Eastern Europe, the Middle East, Africa, Asia, and Australia. He is skilled in healthcare systems, strategic planning, talent development, and cultural transformation. He holds a Master’s in Pharmacology and Toxicology from the American University of Beirut.

Richard van Witzenburg

With 20+ years of strategic and operational experience in international healthcare, Richard has managed a broad range of therapeutic areas in Specialty Markets (Women’s Health, Endocrinology, Transplantation and Immunology, Infectious Diseases, Respiratory, Oncology, CNS) and in Mass Markets (Corporate Branded Generics) on country, regional and global levels. His career spanned across Germany, Belgium, Switzerland and Singapore with Novartis, Merck Serono and Teva Pharmaceuticals. Richard has a Life Sciences and Business background, with an MSc in Molecular Biology from the University of Amsterdam and an MBA from the Rotterdam School of Management, Erasmus University.

Guido Mitchell

Guido is an accomplished international business leader in MedTech with an extensive track record of successfully leading commercial organizations in both mature and emerging markets across Europe, North America, and Asia. He has gained significant recognition for his pivotal role in leading the global commercial transformation of Roche’s Diabetes Care business unit, establishing it as a digitally enabled organization. His early adoption and support of digital health make him a seasoned professional in developing digital healthcare solutions with a strong emphasis on enhancing patients’ lives. Guido holds a Master’s degree in Business Administration from the University of Mannheim, Germany, and two diplomas from Coach Akademie Switzerland, specializing in systemic coaching and business coaching. 

ANSEA - GLOBAL PARTNER NETWORK
Enabling us to provide expertise across multiple geographies in local languages

Our partners possess deep expertise in the local healthcare landscape, including strong stakeholder relationships and a nuanced understanding of the healthcare dynamics in the region.

This allows us to deliver customized solutions to our clients that are tailored to the unique needs of each market. By leveraging our partner network, we can tap into the local knowledge and expertise necessary to deliver effective solutions in even the most complex markets.

Global Nexus
ANSEA - Elite Partner Network
  • Argentina
  • ANZ
  • Brazil
  • China
  • Colombia
  • France
  • Germany
  • GCC + Egypt
  • Hong Kong
  • India
  • Indonesia
  • Italy
  • Japan
  • Korea
  • Malaysia
  • Mexico
  • Philippines
  • Peru
  • Singapore
  • Spain
  • Switzerland
  • Taiwan
  • Thailand
  • UK

Argentina

Brazil

China

Columbia

France

Germany

GCC + Egypt

Hongkong

India

Indonesia

Italy

Japan

Korea

Malaysia

Mexico

Philippines

Peru

Singapore

Spain

Switzerland

Taiwan

Thailand

United Kingdom